 Short-sellers who made a bet on Esperion Therapeutics Inc. ESPR , Financial have done well during the past year, but is it time to cash out? While Experions share price has been cut nearly 30 to about 20 during the past 52 weeks, investment professionals are projecting a reversal of fortune. 